IRIS Accounts Production v25.1.3.33 04492333 director 1.12.23 30.11.24 30.11.24 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh044923332023-11-30044923332024-11-30044923332023-12-012024-11-30044923332022-11-30044923332022-12-012023-11-30044923332023-11-3004492333ns15:EnglandWales2023-12-012024-11-3004492333ns14:PoundSterling2023-12-012024-11-3004492333ns10:Director12023-12-012024-11-3004492333ns10:PrivateLimitedCompanyLtd2023-12-012024-11-3004492333ns10:SmallEntities2023-12-012024-11-3004492333ns10:AuditExempt-NoAccountantsReport2023-12-012024-11-3004492333ns10:SmallCompaniesRegimeForDirectorsReport2023-12-012024-11-3004492333ns10:SmallCompaniesRegimeForAccounts2023-12-012024-11-3004492333ns10:FullAccounts2023-12-012024-11-300449233312023-12-012024-11-3004492333ns10:CompanySecretary12023-12-012024-11-3004492333ns10:RegisteredOffice2023-12-012024-11-3004492333ns5:CurrentFinancialInstruments2024-11-3004492333ns5:CurrentFinancialInstruments2023-11-3004492333ns5:Non-currentFinancialInstruments2024-11-3004492333ns5:Non-currentFinancialInstruments2023-11-3004492333ns5:ShareCapital2024-11-3004492333ns5:ShareCapital2023-11-3004492333ns5:RetainedEarningsAccumulatedLosses2024-11-3004492333ns5:RetainedEarningsAccumulatedLosses2023-11-3004492333ns5:NetGoodwill2023-12-012024-11-3004492333ns5:IntangibleAssetsOtherThanGoodwill2023-12-012024-11-3004492333ns5:LandBuildings2023-12-012024-11-3004492333ns5:PlantMachinery2023-12-012024-11-3004492333ns5:NetGoodwill2023-11-3004492333ns5:NetGoodwill2024-11-3004492333ns5:NetGoodwill2023-11-3004492333ns5:LandBuildings2023-11-3004492333ns5:PlantMachinery2023-11-3004492333ns5:LandBuildings2024-11-3004492333ns5:PlantMachinery2024-11-3004492333ns5:LandBuildings2023-11-3004492333ns5:PlantMachinery2023-11-3004492333ns5:WithinOneYearns5:CurrentFinancialInstruments2024-11-3004492333ns5:WithinOneYearns5:CurrentFinancialInstruments2023-11-3004492333ns5:DeferredTaxation2023-11-3004492333ns5:DeferredTaxation2023-12-012024-11-3004492333ns5:DeferredTaxation2024-11-30
REGISTERED NUMBER: 04492333 (England and Wales)















Unaudited Financial Statements for the Year Ended 30 November 2024

for

Avonmouth Pharmacy Limited

Avonmouth Pharmacy Limited (Registered number: 04492333)






Contents of the Financial Statements
for the Year Ended 30 November 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Avonmouth Pharmacy Limited

Company Information
for the Year Ended 30 November 2024







DIRECTOR: K G Murphy





SECRETARY: N R C Standeven F.C.A.





REGISTERED OFFICE: 122 Winchcombe Street
Cheltenham
Gloucestershire
GL52 2NW





REGISTERED NUMBER: 04492333 (England and Wales)





ACCOUNTANTS: Crossley and Co.
122 Winchcombe Street
Cheltenham
Gloucestershire
GL52 2NW

Avonmouth Pharmacy Limited (Registered number: 04492333)

Balance Sheet
30 November 2024

30.11.24 30.11.23
Notes £    £    £   
FIXED ASSETS
Intangible assets 4 - -
Tangible assets 5 159,885 159,885
159,885 159,885

CURRENT ASSETS
Stocks 53,382 57,388
Debtors 6 933,778 881,642
Cash at bank and in hand 85,784 50,474
1,072,944 989,504
CREDITORS
Amounts falling due within one year 7 407,334 408,892
NET CURRENT ASSETS 665,610 580,612
TOTAL ASSETS LESS CURRENT
LIABILITIES

825,495

740,497

CREDITORS
Amounts falling due after more than one
year

8

(106,690

)

(43,194

)

PROVISIONS FOR LIABILITIES 9 (10,497 ) (11,913 )
NET ASSETS 708,308 685,390

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 708,208 685,290
SHAREHOLDERS' FUNDS 708,308 685,390

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 November 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 November 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Avonmouth Pharmacy Limited (Registered number: 04492333)

Balance Sheet - continued
30 November 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 11 March 2025 and were signed by:





K G Murphy - Director


Avonmouth Pharmacy Limited (Registered number: 04492333)

Notes to the Financial Statements
for the Year Ended 30 November 2024

1. STATUTORY INFORMATION

Avonmouth Pharmacy Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 0, is being amortised evenly over its estimated useful life of nil years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Land and buildings - not provided
Plant and machinery etc - 25% on reducing balance and 20% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Avonmouth Pharmacy Limited (Registered number: 04492333)

Notes to the Financial Statements - continued
for the Year Ended 30 November 2024

2. ACCOUNTING POLICIES - continued

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 8 (2023 - 7 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 December 2023
and 30 November 2024 1
AMORTISATION
At 1 December 2023
and 30 November 2024 1
NET BOOK VALUE
At 30 November 2024 -
At 30 November 2023 -

5. TANGIBLE FIXED ASSETS
Plant and
Land and machinery
buildings etc Totals
£    £    £   
COST
At 1 December 2023
and 30 November 2024 104,637 295,231 399,868
DEPRECIATION
At 1 December 2023
and 30 November 2024 48,321 191,662 239,983
NET BOOK VALUE
At 30 November 2024 56,316 103,569 159,885
At 30 November 2023 56,316 103,569 159,885

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.11.24 30.11.23
£    £   
Trade debtors 147,680 102,256
Amounts owed by group undertakings 766,960 760,710
Other debtors 19,138 18,676
933,778 881,642

Avonmouth Pharmacy Limited (Registered number: 04492333)

Notes to the Financial Statements - continued
for the Year Ended 30 November 2024

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.11.24 30.11.23
£    £   
Bank loans and overdrafts 21,438 26,491
Hire purchase contracts - 18,038
Trade creditors 174,147 218,329
Taxation and social security 49,917 31,608
Other creditors 161,832 114,426
407,334 408,892

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
30.11.24 30.11.23
£    £   
Bank loans 106,690 43,194

Amounts falling due in more than five years:

Repayable by instalments
Bank loans more 5 yr by instal 106,690 43,194

9. PROVISIONS FOR LIABILITIES
30.11.24 30.11.23
£    £   
Deferred tax 10,497 11,913

Deferred
tax
£   
Balance at 1 December 2023 11,913
Provided during year (1,416 )
Balance at 30 November 2024 10,497